- ICH GCP
- Yhdysvaltain kliinisten tutkimusten rekisteri
- Kliininen tutkimus NCT03435367
Immersive Virtual Reality to Reduce Procedural Pain During IV Insertion in Children in the Emergency Department
maanantai 7. lokakuuta 2019 päivittänyt: Jennifer Stinson, The Hospital for Sick Children
Immersive Virtual Reality to Reduce Procedural Pain During IV Insertion in Children in the Emergency Department: A Feasibility Pilot Study
Venipuncture and intravenous (IV) access continue to be the most common causes of pain and distress among children in the pediatric emergency department.
Virtual reality has been successful for reducing pain and fear in many clinical scenarios, including port access in oncology patients, anxiety disorders, phobias, burn and wound care and others.
There is only one previous study examining virtual reality distraction to reduce procedural pain during IV insertion in pediatric patients and no previous studies examining this in the emergency department setting.
In this study, the investigators will compare immersive virtual reality (an interactive underwater environment) to the current standard (tablet device/iPad playing a movie) for distraction to reduce procedural pain during IV insertion.
The investigators hypothesize that the immersive quality of the virtual reality will reduce patient's pain scores, fear scores and tachycardia during and after the procedure, and have minimal effect on departmental flow and nursing satisfaction.
If this feasibility pilot study yields positive results, the investigators plan to expand to a larger randomized control trial.
Tutkimuksen yleiskatsaus
Tila
Valmis
Interventio / Hoito
Yksityiskohtainen kuvaus
This study is a pilot randomized control trial that aims to (a) to determine the differences in self-reported and proxy-reported pain and fear during IV insertion between the interactive VR intervention and control group, and (b) to assess the feasibility (safety, acceptability) of the VR intervention to children/families and the healthcare team in the pediatric emergency department.
The study will consist of two study arms, where both study arms will be screened and recruited using the same procedure.
Participants will be randomized into either (1) Control group: child life specialist plays an age-appropriate video on a tablet device, or (2) Intervention (VR Distraction): child life specialist facilitates immersive VR experience.
Both the intervention and control groups will receive standard medical care (e.g., topical anesthetics).
A convenience sample of 80 children and adolescents with cancer (40 participants per treatment arm; 20 boys and 20 girls per treatment arm) will be recruited.
In addition to usual care, children in the experimental condition will wear the VR headset plus headphones.
In the control condition, children will watch a video (i.e., an age-appropriate video selected by an emergency department affiliated child life specialist) on an iPad, while wearing the same headphones as in the experimental condition.
Implementation outcomes include accrual and retention rates, acceptability and technical difficulties.
Effectiveness outcomes include child pain, distress, and fear, as well as parent distress.
Opintotyyppi
Interventio
Ilmoittautuminen (Todellinen)
58
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.
Opiskelupaikat
-
-
Ontario
-
Toronto, Ontario, Kanada, M5G 1X8
- Hospital for Sick Children
-
-
Osallistumiskriteerit
Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.
Kelpoisuusvaatimukset
Opintokelpoiset iät
8 vuotta - 18 vuotta (Lapsi, Aikuinen)
Hyväksyy terveitä vapaaehtoisia
Ei
Sukupuolet, jotka voivat opiskella
Kaikki
Kuvaus
Inclusion criteria will be:
- aged 8-17 years
- able to speak and understand English
- parent/guardian present
- medically stable (CTAS 2, 3, 4 or 5; IV insertion +/-20 minutes will not impact the safety of the patient according to treating medical team)
- requires IV insertion
Exclusion criteria will be:
- visual, auditory or cognitive impairments precluding interaction with the VR intervention or reporting pain and fear
- psychiatric conditions that could be exacerbated by the VR environment (i.e. hallucinations)
- skin, face or ear infections or injuries, which could contaminate the intervention equipment
- medically unstable (CTAS 1; patient requires immediate IV insertion)
Opintosuunnitelma
Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
---|---|
Kokeellinen: Intervention Group (VR)
The patient will be allowed to 'try-out' the VR system (including all auditory and visual features) for ~5 minutes prior to the start of the procedure.
In addition to usual care, consisting of child-life presence and topical analgesics if ordered by the treating medical team, children in the experimental condition will wear the VR HMD plus headphones and hold the VR controller.
|
VR with head mounted display (HMD) and headphones.
|
Active Comparator: Control Group (Standard Care - Video)
The patient will be allowed to watch an age-appropriate video on a tablet device.
The patient will be offered to wear the same headphones as in the experimental condition.
The patient will have the tablet and headphones for ~5 minutes prior to the start of the procedure.
In addition, the patient will receive standard care consisting of a child life specialist and topical analgesics (if ordered by the treating medical team).
|
iPad with headphones
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Change in Pain Intensity
Aikaikkuna: Baseline, 30 minutes after baseline
|
Using an 11 point Numerical Rating Scale (NRS) (0 being no distress at all and 10 being the most distress you can imagine this child or you having) children will self-report their pain and parents, nurses and the researcher will report children's pain BOTH prior to and following the procedure.
|
Baseline, 30 minutes after baseline
|
Change in Child Distress
Aikaikkuna: Baseline, 30 minutes after baseline
|
Using an 11 point Numerical Rating Scale (NRS) (0 being no distress at all and 10 being the most distress you can imagine this child or you having) children will self-report their distress and parents, nurses and the researcher will report children's distress BOTH prior to and following the procedure
|
Baseline, 30 minutes after baseline
|
Change in Child Fear
Aikaikkuna: Baseline, 30 minutes after baseline
|
Children will report fear BOTH prior to and following the procedure using the Child Fear Scale (CFS) which is a 5-face visual scale that measures fear intensity and is validated in children as young as 5 years.
It consists of a 1-question scale rating fear from 0 - 4, based on the faces provided.
A higher number represents higher fear intensity.
|
Baseline, 30 minutes after baseline
|
Child Pain Catastrophizing
Aikaikkuna: Baseline
|
Children will report baseline tendencies to catastrophize about pain using the Pain Catastrophizing Scale - Child (PCS-C).
This is a self-report measure of children's tendency to catastrophize about pain validated in children 8-18 years of age.
6-items responded to on an 11-point scale from 0 ("not at all") to 10 ("a lot"), with a higher number representing higher pain catastrophizing.
|
Baseline
|
Parent Pain Catastrophizing
Aikaikkuna: Baseline
|
Parents will report baseline tendencies to catastrophize about their child's pain using the Pain Catastrophizing Scale - Parent (PCS-P), which is a self-report measure of parents' tendency to catastrophize about their child's pain validated in parents of children 8-18 years of age.
6-items responded to on an 11-point scale from 0 ("not at all") to 10 ("a lot"), with a higher number representing higher parental pain catastrophizing of their child's pain.
|
Baseline
|
Parent Distress
Aikaikkuna: 30 minutes after baseline measures are completed
|
Parents will report on their own level of distress following the child's procedure using the Parent Distress Questionnaire.
This measure consists of 4-items responded to on an 11-point numeric rating scale from 0 ("not at all") to 10 ("extremely").
A higher number value represents higher distress levels.
|
30 minutes after baseline measures are completed
|
Child Presence Measure
Aikaikkuna: 30 minutes after baseline measures are completed
|
This child self-report measure assesses effectiveness of the immersive aspect of the VR toolkit/iPad using 12 questions, a choice of three answers ("no", "a little", and "a lot").
|
30 minutes after baseline measures are completed
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
---|---|---|
Recruitment log
Aikaikkuna: through study completion, an average of 1 year
|
Using an investigator-generated recruitment log, accrual rates will be measured by counting the number eligible children per recruitment day, participants enrolled, reasons for ineligibility, reasons for non-participation and reasons for study attrition.
|
through study completion, an average of 1 year
|
Acceptability
Aikaikkuna: 30 minutes after baseline measures are completed
|
Measured using the VR Distraction Satisfaction Questionnaire completed by children, parents and nurses and will collect data on acceptability, perceived utility of pain reducing procedures, and recommendations for changes related to the needle insertion experience.
|
30 minutes after baseline measures are completed
|
Outcome measure feasibility
Aikaikkuna: through study completion, an average of 1 year
|
Will be measured as the percentage of completed outcome measures at baseline and study completion and will be recorded on the VR Distraction Activity Log.
|
through study completion, an average of 1 year
|
Technical Difficulties Log
Aikaikkuna: through study completion, an average of 1 year
|
Using an investigator-generated technical difficulties log, researchers will record data related to technical difficulties associated with the VR intervention, observed difficulties in implementing the trial protocol in the clinic and time to complete IV needle insertion.
|
through study completion, an average of 1 year
|
Yhteistyökumppanit ja tutkijat
Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.
Sponsori
Opintojen ennätyspäivät
Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan julkisella verkkosivustolla.
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Torstai 1. helmikuuta 2018
Ensisijainen valmistuminen (Todellinen)
Maanantai 30. syyskuuta 2019
Opintojen valmistuminen (Todellinen)
Maanantai 30. syyskuuta 2019
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Perjantai 19. tammikuuta 2018
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Perjantai 9. helmikuuta 2018
Ensimmäinen Lähetetty (Todellinen)
Maanantai 19. helmikuuta 2018
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Keskiviikko 9. lokakuuta 2019
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Maanantai 7. lokakuuta 2019
Viimeksi vahvistettu
Tiistai 1. lokakuuta 2019
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 1000058799
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Ei
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Ei
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .
Kliiniset tutkimukset Virtual Reality Program
-
University of AlbertaAlberta Health servicesRekrytointiVirtuaalitodellisuuden GlenxRose Speech-Language -terapioiden kliininen toteutettavuus ja validointiPuhehäiriöt | Äänihuulun toimintahäiriöKanada
-
Baylor Research InstituteRekrytointiSairaalahoidossa olevat 18-vuotiaat tai sitä vanhemmat kipupotilaatYhdysvallat
-
Tomorrow Sp. z o.o.National Center for Research and Development, PolandValmis
-
University Hospital, AngersRekrytointiAivokasvain | VirtuaalitodellisuusRanska
-
Idan Moshe AderkaValmis
-
Prisma Health-UpstateClemson UniversityValmisNaisen rintojen kasvainYhdysvallat
-
Prisma Health-UpstateClemson UniversityValmis
-
Queen's University, BelfastUniversity of SussexTuntematonVerkkokalvorappeuma | Huono näkyvyys | Albinismi | Stargardtin tauti 1 | Stargardtin tauti 3 | Stargardtin tauti 4Yhdistynyt kuningaskunta
-
University of California, San FranciscoRekrytointiKipu, menettelyllinen | Sedaatiokomplikaatio | Proseduurillinen ahdistusYhdysvallat
-
Henry M. Jackson Foundation for the Advancement...Walter Reed National Military Medical Center; Uniformed Services University... ja muut yhteistyökumppanitValmisTraumaattinen aivovammaYhdysvallat